Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationMultiple MyelomaHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideMyeloablative AgonistsTreatment OutcomeBusulfanGraft vs Host DiseaseLymphoma, Non-HodgkinRemission InductionBone Marrow TransplantationGraft SurvivalAntineoplastic Agents, AlkylatingHematopoietic Stem CellsEtoposideRecurrenceThiotepaSalvage TherapyVincristineCarmustineCytophagocytosisDisease-Free SurvivalIfosfamideAmyloidosisBoronic AcidsPyrazinesThalidomideSurvival RateRetrospective StudiesStem CellsCytarabineDexamethasoneHematopoiesisHodgkin DiseaseCord Blood Stem Cell TransplantationPrednisoneTransplantation ChimeraSurvival AnalysisDoxorubicinNeoplasmsTissue DonorsTime FactorsWhole-Body IrradiationInfectionLymphoma, T-CellAntineoplastic AgentsPOEMS SyndromePlatelet CountHistocompatibilityBone MarrowHistocompatibility TestingFollow-Up StudiesCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteBone Marrow PurgingTransplantation, IsogeneicVidarabinePlasma CellsBlood Cell CountRecombinant ProteinsLeukemiaLymphomaImmunophenotypingPrognosisProspective StudiesFatal OutcomeBlood CellsCytomegalovirus InfectionsGraft vs Leukemia EffectFeasibility StudiesMyeloma ProteinsMyelodysplastic SyndromesFlow CytometryAnemia, AplasticParaproteinemiasBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationLymphocyte DepletionBone Marrow CellsLeukocytes, MononuclearT-LymphocytesHematologic DiseasesOpportunistic InfectionsHistiocytosis, Non-Langerhans-CellLivedo Reticularis